Telmisartan Tablets 40 mg (Telmisartan)

Adult dose

For the treatment of essential hypertension, administer 40 mg of Telmisartan orally once daily with water. It can be taken regardless of meals. It may be started at 20 mg once daily if necessary, and can be increased to a maximum of 80 mg once daily. Dose increments should be made after 4 to 8 weeks of treatment to observe the maximum blood pressure-lowering effect. To reduce the risk of cardiovascular disease, 80 mg once daily is recommended.

This medication can cause serious harm to the fetus and newborn, especially during pregnancy, and should be discontinued immediately if pregnancy is confirmed. Individuals with an allergy to this drug, pregnant or breastfeeding women, patients with severe liver impairment or biliary obstruction, patients with hereditary angioedema, patients with diabetes or severe renal impairment should not take this medication. Elderly patients, those with hyperkalemia, patients with liver impairment, patients with valvular heart disease, patients with ischemic heart disease, patients with gastrointestinal disease, patients with renal artery hypertension, and those with severe renal impairment should use this drug with caution. During treatment, blood pressure, renal function, and serum potassium levels should be regularly monitored to detect and manage adverse reactions early. If any unusual symptoms occur during treatment, such as headache, dizziness, cough, indigestion, myalgia, skin rash, angioedema, hyperkalemia, renal failure, shock, or hepatic dysfunction, consult a physician immediately. Particularly, if symptoms of angioedema occur, immediate treatment may be necessary as it can cause breathing difficulties. This drug may enhance the blood pressure-lowering effect when used with other antihypertensives, so inform your doctor of any medications you are taking. Caution is required when used in combination with certain drugs such as lithium, digoxin, and ramipril, as the risk of side effects may increase. In conditions of reduced blood volume or sodium, hypotensive symptoms may occur, thus prior correction is necessary. It is advisable to discontinue this medication 24 hours before surgery, and caution should be taken when driving or operating machinery due to dizziness or risk of fainting. It is not recommended for children and adolescents as safety and efficacy have not been established. In case of overdose, symptoms such as hypotension, tachycardia, dizziness, and acute renal failure may occur; immediate medical attention is required for appropriate treatment. Store this medication out of reach of children, away from direct sunlight, and be cautious of humidity.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions (anaphylactic reactions, angioedema, laryngeal edema), severe rash accompanied by high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions (toxic skin rash), shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by coughing and fever, liver abnormalities (liver dysfunction, jaundice), sudden

Mild side effects

• Upper respiratory infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

Store this medication in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius.

Appearance

White oval-shaped tablet

Package unit

30 tablets/box [(10 tablets/AluAlu*3)]